251 related articles for article (PubMed ID: 9733761)
1. Regulated Co-translational ubiquitination of apolipoprotein B100. A new paradigm for proteasomal degradation of a secretory protein.
Zhou M; Fisher EA; Ginsberg HN
J Biol Chem; 1998 Sep; 273(38):24649-53. PubMed ID: 9733761
[TBL] [Abstract][Full Text] [Related]
2. Proteasome-mediated degradation of apolipoprotein B targets both nascent peptides cotranslationally before translocation and full-length apolipoprotein B after translocation into the endoplasmic reticulum.
Liao W; Yeung SC; Chan L
J Biol Chem; 1998 Oct; 273(42):27225-30. PubMed ID: 9765244
[TBL] [Abstract][Full Text] [Related]
3. The degradation of apolipoprotein B100 is mediated by the ubiquitin-proteasome pathway and involves heat shock protein 70.
Fisher EA; Zhou M; Mitchell DM; Wu X; Omura S; Wang H; Goldberg AL; Ginsberg HN
J Biol Chem; 1997 Aug; 272(33):20427-34. PubMed ID: 9252351
[TBL] [Abstract][Full Text] [Related]
4. Co-translational interactions of apoprotein B with the ribosome and translocon during lipoprotein assembly or targeting to the proteasome.
Pariyarath R; Wang H; Aitchison JD; Ginsberg HN; Welch WJ; Johnson AE; Fisher EA
J Biol Chem; 2001 Jan; 276(1):541-50. PubMed ID: 11022045
[TBL] [Abstract][Full Text] [Related]
5. Effects of tocotrienol on the intracellular translocation and degradation of apolipoprotein B: possible involvement of a proteasome independent pathway.
Wang Q; Theriault A; Gapor A; Adeli K
Biochem Biophys Res Commun; 1998 May; 246(3):640-3. PubMed ID: 9618265
[TBL] [Abstract][Full Text] [Related]
6. Cytosolic components are required for proteasomal degradation of newly synthesized apolipoprotein B in permeabilized HepG2 cells.
Sakata N; Stoops JD; Dixon JL
J Biol Chem; 1999 Jun; 274(24):17068-74. PubMed ID: 10358059
[TBL] [Abstract][Full Text] [Related]
7. Ubiquitin-dependent and -independent proteasomal degradation of apoB associated with endoplasmic reticulum and Golgi apparatus, respectively, in HepG2 cells.
Liao W; Chang BH; Mancini M; Chan L
J Cell Biochem; 2003 Aug; 89(5):1019-29. PubMed ID: 12874835
[TBL] [Abstract][Full Text] [Related]
8. Translocation efficiency, susceptibility to proteasomal degradation, and lipid responsiveness of apolipoprotein B are determined by the presence of beta sheet domains.
Liang J; Wu X; Jiang H; Zhou M; Yang H; Angkeow P; Huang LS; Sturley SL; Ginsberg H
J Biol Chem; 1998 Dec; 273(52):35216-21. PubMed ID: 9857060
[TBL] [Abstract][Full Text] [Related]
9. The amino-terminal domain of apolipoprotein B does not undergo retrograde translocation from the endoplasmic reticulum to the cytosol. Proteasomal degradation of nascent apolipoprotein B begins at the carboxyl terminus of the protein, while apolipoprotein B is still in its original translocon.
Liang S; Wu X; Fisher EA; Ginsberg HN
J Biol Chem; 2000 Oct; 275(41):32003-10. PubMed ID: 10922368
[TBL] [Abstract][Full Text] [Related]
10. Efficient glycosylation site utilization by intracellular apolipoprotein B. Implications for proteasomal degradation.
Huang XF; Shelness GS
J Lipid Res; 1999 Dec; 40(12):2212-22. PubMed ID: 10588947
[TBL] [Abstract][Full Text] [Related]
11. Translocation-arrested apolipoprotein B evades proteasome degradation via a sterol-sensitive block in ubiquitin conjugation.
Du EZ; Fleming JF; Wang SL; Spitsen GM; Davis RA
J Biol Chem; 1999 Jan; 274(3):1856-62. PubMed ID: 9880570
[TBL] [Abstract][Full Text] [Related]
12. Distribution, transport, and degradation of apolipoprotein B-100 in HepG2 cells.
Sakata N; Phillips TE; Dixon JL
J Lipid Res; 2001 Dec; 42(12):1947-58. PubMed ID: 11734567
[TBL] [Abstract][Full Text] [Related]
13. Tunicamycin induces ubiquitination and degradation of apolipoprotein B in HepG2 cells.
Liao W; Chan L
Biochem J; 2001 Feb; 353(Pt 3):493-501. PubMed ID: 11171045
[TBL] [Abstract][Full Text] [Related]
14. CD4 glycoprotein degradation induced by human immunodeficiency virus type 1 Vpu protein requires the function of proteasomes and the ubiquitin-conjugating pathway.
Schubert U; Antón LC; Bacík I; Cox JH; Bour S; Bennink JR; Orlowski M; Strebel K; Yewdell JW
J Virol; 1998 Mar; 72(3):2280-8. PubMed ID: 9499087
[TBL] [Abstract][Full Text] [Related]
15. Co-translational degradation of apolipoprotein B100 by the proteasome is prevented by microsomal triglyceride transfer protein. Synchronized translation studies on HepG2 cells treated with an inhibitor of microsomal triglyceride transfer protein.
Benoist F; Grand-Perret T
J Biol Chem; 1997 Aug; 272(33):20435-42. PubMed ID: 9252352
[TBL] [Abstract][Full Text] [Related]
16. Apolipoprotein B, a paradigm for proteins regulated by intracellular degradation, does not undergo intracellular degradation in CaCo2 cells.
Liao W; Chan L
J Biol Chem; 2000 Feb; 275(6):3950-6. PubMed ID: 10660549
[TBL] [Abstract][Full Text] [Related]
17. Calnexin and other factors that alter translocation affect the rapid binding of ubiquitin to apoB in the Sec61 complex.
Chen Y; Le Cahérec F; Chuck SL
J Biol Chem; 1998 May; 273(19):11887-94. PubMed ID: 9565615
[TBL] [Abstract][Full Text] [Related]
18. Role of lipid synthesis, chaperone proteins and proteasomes in the assembly and secretion of apoprotein B-containing lipoproteins from cultured liver cells.
Ginsberg HN
Clin Exp Pharmacol Physiol; 1997 May; 24(5):A29-32. PubMed ID: 9143794
[TBL] [Abstract][Full Text] [Related]
19. Ubiquitin-proteasome pathway mediates intracellular degradation of apolipoprotein B.
Yeung SJ; Chen SH; Chan L
Biochemistry; 1996 Oct; 35(43):13843-8. PubMed ID: 8901527
[TBL] [Abstract][Full Text] [Related]
20. Glucosamine-induced endoplasmic reticulum stress promotes ApoB100 degradation: evidence for Grp78-mediated targeting to proteasomal degradation.
Qiu W; Kohen-Avramoglu R; Mhapsekar S; Tsai J; Austin RC; Adeli K
Arterioscler Thromb Vasc Biol; 2005 Mar; 25(3):571-7. PubMed ID: 15618547
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
